Morana Jovan-Embiricos
Managing Partner & Founder @ F2 Ventures
London, United Kingdom
Morana Jovan-Embiricos is a Series A investor at F2 Ventures in London focused on Biotechnology and Medical. Morana Jovan-Embiricos is the Founder & Managing Partner of F2 Ventures & he attended Cambridge University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Morana Jovan-Embiricos invests in
Stages Morana Jovan-Embiricos invests in
Countries Morana Jovan-Embiricos invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Therapeutics 1 (33%)
- Pharmaceutical 1 (33%)
- Alternative Medicine 1 (33%)
Stage
- Series A 2 (67%)
- Series D 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ElevateBio
|
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines.The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elementsthat translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases.Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017. | $401M / Series D / May 24, 2023 | |
Orna Therapeutics
|
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. | $80M / Series A / Feb 24, 2021 | |
|
ElevateBio
|
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines.The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elementsthat translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases.Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017. | $150M / Series A / May 13, 2019 |
Co-Investors
MPM Capital
3 deals together
Redmile Group
2 deals together
Samsara BioCapital
2 deals together
Astellas Venture Management
1 deal together
Bristol-Myers Squibb
1 deal together
EcoR1 Capital
1 deal together
About F2 Ventures
F2 Ventures is a healthcare investment platform focused on arbitrage opportunities across the biotech sector, targeting innovation at the right stage for maximum impact.
F2 Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Morana Jovan-Embiricos
Managing Partner & Founder
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Morana Jovan-Embiricos invest in?
Morana Jovan-Embiricos invests primarily in Biotechnology, Medical and Therapeutics startups, most often at Series A and Series D stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Morana Jovan-Embiricos last invest?
The most recent investment recorded for Morana Jovan-Embiricos closed in May 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
